Aberrant promoter methylation of the retinoic acid receptor alpha gene in acute promyelocytic leukemia

Leukemia

Volumn 19, Issue 12, 2005, Pages 2241-2246

  Chim, C S ^a   Wong, S Y ^a   Pang, A ^a   Chu, P ^a   Lau, J S ^b   Wong, K F ^b   Kwong, Y L ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b QUEEN ELIZABETH HOSPITAL   (Hong Kong)

Author keywords

Aberrant methylation; Acute promyelocytic; RARA

Indexed keywords

AZACITIDINE; HYBRID PROTEIN; ISOPROTEIN; PROMYELOCYTIC LEUKEMIA PROTEIN; RETINOIC ACID; RETINOIC ACID RECEPTOR ALPHA;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ARTICLE; CHROMOSOME ABERRATION; CHROMOSOME TRANSLOCATION; CLINICAL ARTICLE; CONTROLLED STUDY; DEMETHYLATION; DNA METHYLATION; FEMALE; GENE DISRUPTION; GENE TARGETING; HUMAN; LEUKEMIA RELAPSE; LEUKEMIA REMISSION; LEUKEMOGENESIS; LEUKOCYTE COUNT; MALE; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PROMYELOCYTIC LEUKEMIA; PROTEIN EXPRESSION; PROTEIN METHYLATION; STATISTICAL ANALYSIS; SURVIVAL RATE;

EID: 28544440377     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/sj.leu.2403937     Document Type: Article

References (39)

1. De The H, Chomienne C, Lanotte M, Degos L, Dijean A. The t(15;17) translocation of acute promyelocytic leukaemia fuses the retinoic acid receptor α gene to a novel transcribed locus. Nature 347; 558: 1990.
2. Tenen DG, Hromas R, Licht JD, Zhang DE. Transcription factors, normal myeloid development, and leukemia. Blood 1997; 90: 489-519.
3. Chomienne C, Balitrand N, Ballerini P, Castaigne S, de The H, Degos L. All-trans retinoic acid modulates the retinoic acid receptor-alpha in promyelocytic cells. J Clin Invest 1991; 88: 2150-2154.
4. Melnick A, Licht JD. Blood, 1999 Deconstructing a disease: RARalpha, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukemia. Blood 1999; 93: 3167-3215.
5. Chih DY, Chumakov AM, Park DJ, Silla AG, Koeffler HP. Modulation of mRNA expression of a novel human myeloid-selective CCAAT/enhancer binding protein gene (C/EBP epsilon). Blood 1997; 90: 2987-2994.
6. Zelent A, Guidez F, Melnick A, Waxmaan S, Licht JD. Translocations of the RARα gene in acute promyelocytic leukaemia. Oncogene 2001; 20: 7186-7203.
7. Zhu J, Heyworth CM, Glasow A, Huang QH, Petrie K, Lanotte M et al. Lineage restriction of the RARalpha gene expression in myeloid differentiation. Blood 2000; 98: 2563-2567.
8. Collins SJ. The role of retinoids and retinoic acid receptors in normal hematopoiesis. Leukemia 2002; 16: 1896-1905.
9. Lian Z, Kluger Y, Greenbaum DS, Tuck D, Gerstein M, Berliner N et al. Genomic and proteomic analysis of the myeloid differentiation program: global analysis of gene expression during induced differentiation in the MPRO cell line. Blood 2002; 100: 3209-3220.
10. Leroy P, Krust A, Zelent A, Mendelsohn C, Garnier JM, Kastner P et al. Multiple isoforms of the mouse retinoic acid receptor alpha are generated by alternative splicing and differential induction by retinoic acid. EMBO J 1991; 10: 59-69.
11. Baylin SB, Herman JG, Graff JR, Vertino PM, Issa JP. Alterations in DNA methylation: A fundamental aspect of neoplasia. Adv Cancer Res 1998; 72: 141-196.
12. Robertson KD, Wolffe AP. DNA methylation in health and disease. Nat Rev 2000; 1: 11-19.
13. Singal R, Ginder GD. DNA methylation. Blood 1999; 93: 4059-4070.
14. Chim CS, Liang R, Kwong YL. Gene promoter hypermethylation in hematologic malignancies. Hematol Oncol 2002; 20: 167-176.
15. Jones PA, Laird PW. Cancer epigenetics comes of age. Nat Genet 1999; 21: 163-167.
16. Siegfried Z, Eden S, Mendelsohn M, Feng X, Tsuberi BZ, Cedar H. DNA methylation represses transcription in vivo. Nat Genet 1999; 22: 203-206.
17. Chim CS, Liang R, Tam C, Kwong YL. P15 and P16 promoter methylation in acute promyelocytic leukemia. J Clin Oncol 2001; 19: 2033-2040.
18. Chim CS, Tam C, Liang R, Kwong YL. P15 and P16 gene methylation in adult acute leukemia: Lack of prognostic significance. Cancer 2001; 91: 2222-2229.
19. Chim CS, Wong AS, Kwong YL. Infrequent hypermethylation of CEBPA promoter in acute myeloid leukaemia. Br J Haematol 2002; 119: 988-990.
20. Chim CS, Wong ASY, Kwong YL. Aberrant gene promoter methylation in acute promyelocytic leukaemia: Profile and prognostic significance. Br J Haematol 2003; 122: 571-578.
21. Chim CS, Wong ASY, Kwong YL. Absence of p300 methylation in acute leukemias. Cancer Genet Cytogenet 2004; 150: 164-167.
22. Chim CS, Wong ASY, Kwong YL. Epigenetic inactivation of the INK4/cyclin D/cyclin-dependent kinase cell cycle control pathway in acute leukemias. Ann Haematol 2003; 82: 738-742.
23. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR et al. Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group. Br J Haematol 1976; 33: 451-458.
24. Second MIC Cooperative Study Group. Morphologic, immunologic and cytogenetic (MIC) working classification of the acute myeloid leukaemias. Br J Haematol 1988; 68: 487-494.
25. Herman JG, Graff JR, Myohanen S, Nelkin BD, Baylin SB. Methylation-specific PCR: A novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 1996; 93: 9821-9826.
26. Chim CS, Fung TK, Cheung J, Liang R Kwong YL. SOCS1 and SHP1 hypermethylation in multiple myeloma: Implications for epigenetic activation of the Jak/STAT pathway. Blood 2004; 103: 4630-4635.
27. Pang A, Au WY, Kwong YL. Caveolin-1 gene is coordinately regulated with the multidrug resistance 1 gene in normal and leukemic bone marrow. Leukemia Res 2004; 28: 973-977.
28. Pandolfi PP. In vivo analysis of the molecular genetics of acute promyelocytic leukemia. Oncogene 2001; 20: 5726-5735.
29. Morosetti R, Grignani F, Liberatore C, Pelicci PG, Schiller GJ, Kizaki M et al. Infrequent alterations of the RAR alpha gene in acute myelogenous leukemias, retinoic acid-resistant acute promyelocytic leukemias, myelodysplastic syndromes, and cell lines. Blood 1996; 87: 4399-4403.
30. Parrado A, West R, Jordan D, Bastard C, McKenna S, Whittaker JA et al. Alterations of the retinoic acid receptor alpha (RAR alpha) gene in myeloid and lymphoid malignancies. Br J Haematol 1999; 104: 738-741.
31. Yoshida H, Naoe T, Fukutani H, Kiyoi H, Kubo K, Ohno R. Analysis of the joining sequences of the t(15;17) translocation in human acute promyelocytic leukemia: Sequence non-specific recombination between the PML and RARA genes within identical short stretches. Genes Chromosomes Cancer 1995; 12: 37-44.
32. Knudson AG. Two genetic hits (more or less) to cancer. Nat Rev Cancer 2001; 1: 157-162.
33. Farias EF, Arapshian A, Bleiweiss IJ, Waxman S, Zelent A, Mira-Y-Lopez R. Retinoic acid receptor alpha2 is a growth suppressor epigenetically silenced in MCF-7 human breast cancer cells. Cell Growth Differ 2002; 13: 335-341.
34. Grignani F, De Matteis S, Nervi C, Tomassoni L, Gelmetti V, Cioce M et al. Fusion proteins of the retinoic acid receptor-alpha recruit histone deacetylase in promyelocytic leukaemia. Nature 1998; 391: 815-818.
35. Di Croce L, Raker VA, Corsaro M, Fazi F, Fanelli M, Faretta M et al. Methyltransferase recruitment and DNA hypermethylation of target promoters by an oncogenic transcription factor. Science 2002; 295: 1079-1082.
36. Labrecque J, Allan D, Chambon P, Iscove NN, Lohnes D, Hoang T. Impaired granulocytic differentiation in vitro in hematopoietic cells lacking retinoic acid receptors alpha1 and gamma. Blood 1998; 92: 607-615.
37. Esteller M, Fraga MF, Paz MF, Campo E, Colomer D, Novo FJ et al. Cancer epigenetics and methylation. Science 2002; 297: 1807-1808.
38. He LZ, Tribioli C, Rivi R, Peruzzi D, Pelicci PG, Soares V et al. Acute leukemia with promyelocytic features in PML/RARalpha transgenic mice. Proc Natl Acad Sci USA 1997; 94: 2551-2556.
39. Brown D, Kogan S, Lagasse E, Weissman I, Alcalay M, Pelicci PG et al. A PMLRARalpha transgene initiates murine acute promyelocytic leukemia. Proc Natl Acad Sci USA 1997; 94: 2551-2556.